Close Menu

NEW YORK (360Dx) – Capitala Group announced today it invested a combination of senior secured debt and equity totaling $19.5 million in Shoreline, Washington-based immunology and allergy testing lab US BioTek Laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.